{"id":55272,"date":"2023-03-28T17:07:20","date_gmt":"2023-03-28T15:07:20","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/lunaphore-expands-its-comet-portfolio-to-become-the-first-universal-end-to-end-spatial-biology-solution\/"},"modified":"2023-03-28T17:07:20","modified_gmt":"2023-03-28T15:07:20","slug":"lunaphore-expands-its-comet-portfolio-to-become-the-first-universal-end-to-end-spatial-biology-solution","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/lunaphore-expands-its-comet-portfolio-to-become-the-first-universal-end-to-end-spatial-biology-solution\/","title":{"rendered":"Lunaphore Expands Its COMET\u2122 Portfolio to Become the First Universal, End-to-end Spatial Biology Solution"},"content":{"rendered":"
\n

\nNew products will accelerate the adoption and scalability of groundbreaking translational and clinical research<\/b>\n<\/p>\n

<\/a>
<\/a><\/p>\n

LAUSANNE, Switzerland–(BUSINESS WIRE)–#spatialbiology<\/a>—Lunaphore<\/a><\/b><\/span>, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, today announced the launch of a full expansion of its product offering to provide a universal, end-to-end spatial biology solution, answering the needs of the scientific community from early discovery to late-stage translational and clinical research. This milestone marks the launch of the enhanced version of the company\u2019s revolutionary COMET\u2122<\/a><\/b><\/span> platform and its comprehensive product suite, which includes a wide range of tools and applications across all research and drug development stages.\n<\/p>\n

\nLunaphore\u2019s multiplex immunofluorescence (mIF) solution portfolio now includes the latest version of the hyperplex, high-throughput, fully automated COMET\u2122 instrument, providing unmatched scalability and reproducibility without the need to conjugate primary antibodies. The new SPYRE\u2122<\/b> Antibody Panel kits<\/b><\/a>, Secondary Antibodies<\/b><\/a>, and an online Panel Builder<\/b><\/a> have been added to the existing offering to help kick-start assay development and enable users with verified biomarkers on COMET\u2122.\n<\/p>\n

\nThe product suite is further complemented by HORIZON\u2122<\/a><\/b><\/span>, an image analysis software designed and tailored for COMET\u2122 hyperplex images. The software is developed by biologists for biologists to support them in answering fundamental questions about cell profiling and tissue mapping. With Lunaphore\u2019s universal portfolio of precision automation solutions, customers can leverage their existing antibody libraries and decades of know-how on Lunaphore\u2019s platform to scale assays into endless multiplexing possibilities.\n<\/p>\n

\n\u201cThe spatial biology field is at an inflection point, and Lunaphore is at the forefront of this movement with its radically differentiated technological approach. Since the release of the first COMET\u2122 platform a year ago, we so far observed high customer satisfaction and unmatched traction,\u201d said Ata Tuna Ciftlik, CEO at Lunaphore. \u201cWe are really excited to launch our comprehensive future-ready solutions. This new COMET\u2122 product suite embeds more than ten years of cutting-edge innovation into powerful tools that accompany our customers, from instant assay creation to streamlined research and analytics. We believe that the COMET \u2122 product suite is a cornerstone solution that will make spatial biology an everyday tool in laboratories around the globe.\u201d\n<\/p>\n

\n\u201cA lot of work in our unit is around preclinical and trial work. We immediately recognized COMET\u2122 as the top platform we were after,\u201d said Dr. Andrew Filer, Head of the Birmingham Tissue Analytics Facility at the University of Birmingham. \u201cWe wanted a very high plex, fast, and robust instrument. All of the other platforms that were just coming into the market would have one major failure. The reason we liked COMET\u2122 is that it doesn\u2019t have any significant weaknesses. It covers all the bases, which is really important to us.\u201d\n<\/p>\n

\nLunaphore\u2019s complete product portfolio will be showcased at the American Association for Cancer Research (AACR) 2023 Annual Meeting through a series of activities and at the Lunaphore booth (#1870). To book a meeting or find out more about Lunaphore\u2019s presence at the conference, please visit Lunaphore\u2019s website<\/a>.\n<\/p>\n

\nTo learn more about the new products in Lunaphore\u2019s universal, end-to-end solution or start placing requests, please get in touch with the team at: info@lunaphore.com<\/a>\n<\/p>\n

\nTo learn more about Lunaphore, please visit: https:\/\/lunaphore.com\/<\/a>\n<\/p>\n

\nAbout Lunaphore<\/b>\n<\/p>\n

\nLunaphore Technologies S.A. is a Swiss company born in 2014 with the vision of enabling spatial biology in every laboratory. Lunaphore provides solutions based on a game-changing chip technology that can extract spatial proteomic and transcriptomic data from tumors and other tissues, transforming any assay into multiplex spatial biology through a streamlined and easily integrated process. Lunaphore empowers researchers in immunology, immuno-oncology, and neuroscience to push the boundaries of scientific discovery and drug development. Lunaphore\u2019s technology enables the identification of biomarker \u201csignatures\u201d with clinical relevance to support the development of diagnostic tools and streamline clinical trials, to ultimately improve patient outcomes. For further information on Lunaphore and its products, please visit https:\/\/lunaphore.com<\/a>.\n<\/p>\n

\nAbout COMET\u2122<\/b>\n<\/p>\n

\nCOMET\u2122 is the only fully automated, high-throughput, hyperplex platform ensuring scalability and reproducibility without the need to conjugate primary antibodies. COMET\u2122 provides walk-away automation, integrating staining, imaging, and image preprocessing steps to obtain standard hyperplex images. COMET\u2122 generates highly robust and reproducible data with full tissue preservation, allowing researchers to perform downstream modalities such as H&E or transcriptomics using the same slide. Its superior tissue profiling capabilities facilitate the analysis of 40 different spatial markers in each automated run on a tissue slide. In contrast to other spatial biology solutions, COMET\u2122 works with off-the-shelf, label-free primary antibodies, making panel design much more flexible and faster than any other hyperplex solution. COMET\u2122 works with regular glass slides from standard histology workflows; it is validated for human and mouse samples and is compatible with any other animal sample. The platform can be used for a wide range of research applications, allowing for a dramatic improvement in the understanding of disease pathology. Orders of the new COMET\u2122 version can be placed and will be available for shipment in the upcoming months. To learn more about the COMET\u2122 platform, please visit: https:\/\/lunaphore.com\/products\/comet\/<\/a>\n<\/p>\n

\nAbout HORIZON\u2122<\/b>\n<\/p>\n

\nHORIZON\u2122 is a tissue analysis software designed to simplify image analysis and evaluation. Tailored to COMET\u2122 hyperplex immunofluorescence images, HORIZON\u2122 extends the COMET\u2122 workflow, providing a seamless integration between both systems, from a hyperplex image to cell phenotyping. HORIZON\u2122 leverages COMET\u2122-generated images and associated protocol information instantaneously. It can support assay development on COMET\u2122, as well as image analysis workflows, by rapidly obtaining precise single-cell data for custom downstream analysis. HORIZON\u2122 can perform cell segmentation in a few clicks thanks to a COMET\u2122-specific, pre-trained algorithm, and the user-friendly and intuitive interface enables hyperplex analysis with no coding experience. With HORIZON\u2122, it is possible to take full control of hyperplex data, visualizing all image channels with full flexibility and accurately finetuning histograms to see the adjustments applied instantly. The pre-release of HORIZON\u2122 is now available for COMET\u2122 users. To learn more about the HORIZON\u2122 software, please visit: https:\/\/lunaphore.com\/products\/horizon\/<\/a>\n<\/p>\n

\nAbout SPYRE\u2122 Antibody Panel kits<\/b>\n<\/p>\n

\nThe four SPYRE\u2122 Antibody Panel kits – Immuno-Oncology, Immune, TIL, and T cell Core Panel \u2013 lay the foundation of Lunaphore\u2019s primary antibody offering and establish the basis for the immuno-oncology reagent portfolio. The assays developed with these kits can be modified or expanded with additional off-the-shelf antibodies from the customer\u2019s own library to build custom panels for specific research needs without complexity. The primary antibody offering also includes Panel Builder, an online application providing exclusive access to a library of more than 70 successfully tested off-the-shelf markers and over 300 protocols. It provides an intuitive and convenient way to combine antibodies with SPYRE\u2122 Antibody Panels to create panel protocols in silico<\/i>, allowing ready-to-use COMET\u2122 hyperplex protocols to be automatically generated in a few clicks. Orders of SPYRE\u2122 Antibody Panel kits can be placed and will be available for shipment by the summer. To learn more about SPYRE\u2122 Antibody Panels, please visit: https:\/\/lunaphore.com\/spyre-antibody-panels\/<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nFor further information contact:
\n
Irene Tamayo<\/b>
Lunaphore Corporate Communications
\n
Email: communications@lunaphore.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

New products will accelerate the adoption and scalability of groundbreaking translational and clinical research LAUSANNE, Switzerland–(BUSINESS WIRE)–#spatialbiology—Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, today announced the launch of a full expansion of its product offering to provide a universal, end-to-end spatial biology solution, answering the needs of … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55272","6":"format-standard","7":"category-industry"},"yoast_head":"\nLunaphore Expands Its COMET\u2122 Portfolio to Become the First Universal, End-to-end Spatial Biology Solution - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/lunaphore-expands-its-comet-portfolio-to-become-the-first-universal-end-to-end-spatial-biology-solution\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lunaphore Expands Its COMET\u2122 Portfolio to Become the First Universal, End-to-end Spatial Biology Solution - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"New products will accelerate the adoption and scalability of groundbreaking translational and clinical research LAUSANNE, Switzerland–(BUSINESS WIRE)–#spatialbiology—Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, today announced the launch of a full expansion of its product offering to provide a universal, end-to-end spatial biology solution, answering the needs of ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/lunaphore-expands-its-comet-portfolio-to-become-the-first-universal-end-to-end-spatial-biology-solution\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-28T15:07:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230328005685\/en\/1749314\/21\/Lunaphore_solution_portfolio_2023.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lunaphore-expands-its-comet-portfolio-to-become-the-first-universal-end-to-end-spatial-biology-solution\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lunaphore-expands-its-comet-portfolio-to-become-the-first-universal-end-to-end-spatial-biology-solution\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Lunaphore Expands Its COMET\u2122 Portfolio to Become the First Universal, End-to-end Spatial Biology Solution\",\"datePublished\":\"2023-03-28T15:07:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lunaphore-expands-its-comet-portfolio-to-become-the-first-universal-end-to-end-spatial-biology-solution\\\/\"},\"wordCount\":1192,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lunaphore-expands-its-comet-portfolio-to-become-the-first-universal-end-to-end-spatial-biology-solution\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230328005685\\\/en\\\/1749314\\\/21\\\/Lunaphore_solution_portfolio_2023.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lunaphore-expands-its-comet-portfolio-to-become-the-first-universal-end-to-end-spatial-biology-solution\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lunaphore-expands-its-comet-portfolio-to-become-the-first-universal-end-to-end-spatial-biology-solution\\\/\",\"name\":\"Lunaphore Expands Its COMET\u2122 Portfolio to Become the First Universal, End-to-end Spatial Biology Solution - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lunaphore-expands-its-comet-portfolio-to-become-the-first-universal-end-to-end-spatial-biology-solution\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lunaphore-expands-its-comet-portfolio-to-become-the-first-universal-end-to-end-spatial-biology-solution\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230328005685\\\/en\\\/1749314\\\/21\\\/Lunaphore_solution_portfolio_2023.jpg\",\"datePublished\":\"2023-03-28T15:07:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lunaphore-expands-its-comet-portfolio-to-become-the-first-universal-end-to-end-spatial-biology-solution\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lunaphore-expands-its-comet-portfolio-to-become-the-first-universal-end-to-end-spatial-biology-solution\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lunaphore-expands-its-comet-portfolio-to-become-the-first-universal-end-to-end-spatial-biology-solution\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230328005685\\\/en\\\/1749314\\\/21\\\/Lunaphore_solution_portfolio_2023.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230328005685\\\/en\\\/1749314\\\/21\\\/Lunaphore_solution_portfolio_2023.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lunaphore-expands-its-comet-portfolio-to-become-the-first-universal-end-to-end-spatial-biology-solution\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lunaphore Expands Its COMET\u2122 Portfolio to Become the First Universal, End-to-end Spatial Biology Solution\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lunaphore Expands Its COMET\u2122 Portfolio to Become the First Universal, End-to-end Spatial Biology Solution - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/lunaphore-expands-its-comet-portfolio-to-become-the-first-universal-end-to-end-spatial-biology-solution\/","og_locale":"en_US","og_type":"article","og_title":"Lunaphore Expands Its COMET\u2122 Portfolio to Become the First Universal, End-to-end Spatial Biology Solution - Pharma Trend","og_description":"New products will accelerate the adoption and scalability of groundbreaking translational and clinical research LAUSANNE, Switzerland–(BUSINESS WIRE)–#spatialbiology—Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, today announced the launch of a full expansion of its product offering to provide a universal, end-to-end spatial biology solution, answering the needs of ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/lunaphore-expands-its-comet-portfolio-to-become-the-first-universal-end-to-end-spatial-biology-solution\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-28T15:07:20+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230328005685\/en\/1749314\/21\/Lunaphore_solution_portfolio_2023.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/lunaphore-expands-its-comet-portfolio-to-become-the-first-universal-end-to-end-spatial-biology-solution\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/lunaphore-expands-its-comet-portfolio-to-become-the-first-universal-end-to-end-spatial-biology-solution\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Lunaphore Expands Its COMET\u2122 Portfolio to Become the First Universal, End-to-end Spatial Biology Solution","datePublished":"2023-03-28T15:07:20+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/lunaphore-expands-its-comet-portfolio-to-become-the-first-universal-end-to-end-spatial-biology-solution\/"},"wordCount":1192,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/lunaphore-expands-its-comet-portfolio-to-become-the-first-universal-end-to-end-spatial-biology-solution\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230328005685\/en\/1749314\/21\/Lunaphore_solution_portfolio_2023.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/lunaphore-expands-its-comet-portfolio-to-become-the-first-universal-end-to-end-spatial-biology-solution\/","url":"https:\/\/pharma-trend.com\/en\/lunaphore-expands-its-comet-portfolio-to-become-the-first-universal-end-to-end-spatial-biology-solution\/","name":"Lunaphore Expands Its COMET\u2122 Portfolio to Become the First Universal, End-to-end Spatial Biology Solution - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/lunaphore-expands-its-comet-portfolio-to-become-the-first-universal-end-to-end-spatial-biology-solution\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/lunaphore-expands-its-comet-portfolio-to-become-the-first-universal-end-to-end-spatial-biology-solution\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230328005685\/en\/1749314\/21\/Lunaphore_solution_portfolio_2023.jpg","datePublished":"2023-03-28T15:07:20+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/lunaphore-expands-its-comet-portfolio-to-become-the-first-universal-end-to-end-spatial-biology-solution\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/lunaphore-expands-its-comet-portfolio-to-become-the-first-universal-end-to-end-spatial-biology-solution\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/lunaphore-expands-its-comet-portfolio-to-become-the-first-universal-end-to-end-spatial-biology-solution\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230328005685\/en\/1749314\/21\/Lunaphore_solution_portfolio_2023.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230328005685\/en\/1749314\/21\/Lunaphore_solution_portfolio_2023.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/lunaphore-expands-its-comet-portfolio-to-become-the-first-universal-end-to-end-spatial-biology-solution\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Lunaphore Expands Its COMET\u2122 Portfolio to Become the First Universal, End-to-end Spatial Biology Solution"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55272","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55272"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55272\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55272"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55272"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55272"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}